Amarin reported $35.81M in Cost of Sales for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4142M 121M
Aerie Pharmaceuticals AERI:US $ 3.74M 3.04M
Alnylam Pharmaceuticals ALNY:US $ 40.81M 5.18M
Amarin AMRN:US $ 35.81M 13.57M
AstraZeneca AZN:LN 156386.94M 17145.23M
Biocryst Pharmaceuticals BCRX:US $ 0.25M 0.01M
Epizyme EPZM:US $ 5.17M 2.53M
Esperion Therapeutics ESPR:US $ 9.18M 2.05M
GlaxoSmithKline GSK:LN 213600M 55400M
Halozyme Therapeutics HALO:US $ 33.94M 18.02M
Heron Therapeutics HRTX:US $ 16.18M 4.82M
Intercept Pharmaceuticals ICPT:US $ 0.31M 0.45M
IONIS PHARMACEUT IONS:US $ 4.74M 0.57M
JAZZ PHA JAZZ:US $ 124.21M 8.92M
Nektar Therapeutics NKTR:US $ 5.12M 0.2M
Neurocrine Biosciences NBIX:US $ 4.8M 0.2M
Novartis NOVN:VX SF 3749M 6M
Teva Pharmaceutical Industries TEVA:US $ 1958M 99M